brusatol has been researched along with Cancer of Pituitary in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, L; Li, Q; Lu, J; Su, Z; Wang, C; Wu, Z; Xu, J; Xu, Y | 1 |
1 other study(ies) available for brusatol and Cancer of Pituitary
| Article | Year |
|---|---|
Brusatol Inhibits Tumor Growth and Increases the Efficacy of Cabergoline against Pituitary Adenomas.
Topics: Adenoma; Animals; Cabergoline; Dopamine Agonists; Female; Humans; Mice; Mice, Nude; Pituitary Neoplasms; Quassins; Xenograft Model Antitumor Assays | 2021 |